Quantumzyme Corp.
Other OTCTotal Valuation
Quantumzyme Corp. carries a market capitalization of 31.17M, placing it among publicly traded companies globally.
| Market Cap | 31.17M |
| Enterprise Value | N/A |
Share Statistics
Quantumzyme Corp. currently has 40.97M shares outstanding.
| Shares Outstanding | 40.97M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -13.06 |
| P/TBV Ratio | -312.68 |
| P/FCF Ratio | -1,095.40 |
| P/OCF Ratio | -1,095.40 |
Financial Position
Quantumzyme Corp. maintains a current ratio of 0.00, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.00 |
| Quick Ratio | 0.00 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -5.55 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -1.39M |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Quantumzyme Corp.'s stock has gained approximately 5.26316% over the past 52 weeks. The 50-day moving average sits at 2.67, while the 200-day moving average is 1.04.
| Beta (5Y) | N/A |
| 52-Week Price Change | 5.26316% |
| 50-Day Moving Average | 2.67 |
| 200-Day Moving Average | 1.04 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -135,647.00, while operating income came in at -135,647.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -135,647.00 |
| Pretax Income | -4.48M |
| Net Income | -4.48M |
| EBITDA | -135,647.00 |
| EBIT | -135,647.00 |
| Earnings Per Share (EPS) | -0.12 |
Balance Sheet
Total book value stands at -10.02M, with working capital of -418,342.00 providing operational flexibility.
| Cash & Cash Equivalents | 59.00 |
| Total Debt | N/A |
| Net Debt | 232,007.00 |
| Equity (Book Value) | -10.02M |
| Book Value Per Share | -0.27 |
| Working Capital | -418,342.00 |
Cash Flow
Quantumzyme Corp. produced -119,416.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -119,416.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -119,416.00 |
| FCF Per Share | 0.00 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.09 |
| FCF Yield | -0.09 |
Scores
Quantumzyme Corp. posts an Altman Z-Score of -253,578.08, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -253,578.08 |